Rameen Beroukhim
Rameen Beroukhim
Dana-Farber Cancer Institute, Harvard Medical School
Verified email at broadinstitute.org - Homepage
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
D Koboldt, R Fulton, M McLellan, H Schmidt, J Kalicki-Veizer, ...
Nature 490 (7418), 61-70, 2012
80382012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas (TCGA) Research Network
Nature 455 (7216), 1061, 2008
57962008
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
34562013
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
33602010
Comprehensive molecular characterization of gastric adenocarcinoma
AJ Bass, V Thorsson, I Shmulevich, SM Reynolds, M Miller, B Bernard, ...
Nature 513 (7517), 202, 2014
32132014
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43, 2013
2502*2013
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
24292013
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
Cancer Genome Atlas Research Network
New England Journal of Medicine 372 (26), 2481-2498, 2015
19042015
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
19022014
GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
CH Mermel, SE Schumacher, B Hill, ML Meyerson, R Beroukhim, G Getz
Genome biology 12 (4), 1-14, 2011
17932011
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
16692015
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff, MY Wang, I Vivanco, DA Haas-Kogan, S Zhu, EQ Dia, ...
New England Journal of Medicine 353 (19), 2012-2024, 2005
16172005
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
16092015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
16062018
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ...
Nature 436 (7047), 117-122, 2005
15772005
Molecular definition of breast tumor heterogeneity
M Shipitsin, LL Campbell, P Argani, S Weremowicz, N Bloushtain-Qimron, ...
Cancer cell 11 (3), 259-273, 2007
15662007
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
15382014
Pan-cancer patterns of somatic copy number alteration
TI Zack, SE Schumacher, SL Carter, AD Cherniack, G Saksena, B Tabak, ...
Nature genetics 45 (10), 1134-1140, 2013
14582013
Absolute quantification of somatic DNA alterations in human cancer
SL Carter, K Cibulskis, E Helman, A McKenna, H Shen, T Zack, PW Laird, ...
Nature biotechnology 30 (5), 413-421, 2012
14322012
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen, R Beroukhim, L Cai, C Brennan, J Lahti-Domenici, H Huang, ...
Cancer cell 6 (1), 17-32, 2004
14212004
The system can't perform the operation now. Try again later.
Articles 1–20